Cite
HARVARD Citation
Folschweiller, N. et al. (2019). Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. Journal of infectious diseases. pp. 1799-1803. [Online].